What development phase is GLUCOSAMINE SULFATE POTASSIUM CHLORIDE in?

GLUCOSAMINE SULFATE POTASSIUM CHLORIDE is FDA-approved (marketed).

Last reviewed 2026-05-14 · How we verify

GLUCOSAMINE SULFATE POTASSIUM CHLORIDE

FDA-approved active Small molecule Quality 2/100

At a glance

Generic name	GLUCOSAMINE SULFATE POTASSIUM CHLORIDE
Modality	Small molecule
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Retrospective Study of ImmunoFormulation for COVID-19
A Study on the Efficacy of Glucosamine Sulfate Potassium Chloride/Standardized Ginkgo Biloba Leaf Extract in Adults With Osteoarthritis of the Knee. (PHASE2)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

GLUCOSAMINE SULFATE POTASSIUM CHLORIDE CI brief — competitive landscape report
GLUCOSAMINE SULFATE POTASSIUM CHLORIDE updates RSS · CI watch RSS